Skip to main content
$1.65 0.05 (3.13%)

High

$1.65

Low

$1.57

Trades

224

Turnover

$153,470

Volume

95,157
30 June 2023 at 4:10pm
If you were already registered, log in here.

Short Interest

ASIC data, 5 Nov 2026

% Shorted

0.02%
vs 0.02% prior report

Most Shorted Rank

555th
of 715 shorted ASX stocks

Peak Short

0.81%
Jul 2023

Days to Cover

0.1
at 50d avg vol
Subject
CGS Ann: Change of Director's Interest Notice - BOC

CGS Ann: Notification regarding unquoted securities - CGS

CGS Ann: CGS tech on Japanese smartphone targeting senior population

CGS Ann: Change in substantial holding from AEF

CGS Ann: Change of Director's Interest Notice - DD

CGS Ann: Constitution and Proportional Takeover Provisions

CGS Ann: Results of Annual General Meeting

CGS Ann: Business Update and September 2021 Qtr Cashflow - Amendment

CGS Ann: 2021 Annual General Meeting Address to Shareholders

CGS Ann: 2021 Annual General Meeting Presentation

CGS Ann: Business Update and September 2021 Quarter Cashflow

CGS Ann: Change of Director's Interest Notice - RVB

CGS Ann: Application for quotation of securities - CGS

CGS Ann: Notification of cessation of securities - CGS

CGS Ann: Notification regarding unquoted securities - CGS

CGS Ann: Cleansing Statement

CGS Ann: Application for quotation of securities - CGS

CGS Ann: Change of Director's Interest Notice - KW

CGS Ann: Notice of Annual General Meeting/Proxy Form

CGS Ann: 2021 AGM Letter to Shareholders and Proxy

CGS Ann: Change in substantial holding from AEF

CGS Ann: Change of Director's Interest Notice - DD

CGS Ann: Change of Director's Interest Notice - MM

CGS Ann: Cleansing Statement

CGS Ann: Application for quotation of securities - CGS

CGS Ann: 2021 Annual General Meeting

CGS Ann: Change in substantial holding

CGS Ann: Investor Presentation - recording available

CGS Ann: Investor Briefing

CGS Ann: FY21 Financial Results & Business Outlook

CGS Ann: Annual Report

CGS Ann: Appendix 4E

CGS Ann: FY21 Appendix 4G and Corporate Governance Statement

CGS Ann: Quarterly Sales Contracts Executed To Date

CGS Ann: Financial results and webcast notification

CGS Ann: Notification of cessation of securities - CGS

CGS Ann: Ceasing to be a substantial holder

CGS Ann: July 2021 Investor Presentation

CGS Ann: June quarter business update and cashflow report

CGS Ann: Value of FY21 Clinical Trials Sales Contracts up 15%

CGS Ann: Change in substantial holding

CGS Ann: Change in substantial holding from AEF

CGS Ann: Loan Forgiven re US Governments Paycheck Protection Program

CGS Ann: Business Update - approval of Alzheimer's therapeutic

CGS Ann: Option Issued Under Employee Share Option Plan

CGS Ann: Appendix 3G

CGS Ann: Unquoted Securities Update Forfeited/Expired

CGS Ann: Investor Presentation

CGS Ann: Appendix 4C - quarterly

CGS Ann: Share Trading Policy

If you were already registered, log in here.

Similar Companies

4DX
ALC
IME
M7T
MDR
PCK
PKS
PME
RAP
S88
MAV
CX8
MTX $12m raise
ATW $7.5m raise
RDO $30m raise
ABC $5m raise
RGS